{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-000894","form_type":"8-K","ticker":"OMER","cik":"0001285819","company_name":"OMEROS CORP","filed_at":"2023-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.225874+00:00","generated_at":"2026-06-19T23:54:39.042643+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Omeros receives $200M milestone payment from Rayner; 2022 OMIDRIA sales $131M","bullets":["Rayner paid $200M milestone plus accrued interest on Feb 3, 2023; U.S. royalty rate drops from 50% to 30%.","Omeros ended 2022 with ~$195M cash; combined with $200M milestone provides funding into at least 2025.","2022 U.S. net sales of OMIDRIA totaled $131M; CAA 2023 secures separate payment for non-opioid pain drugs through Jan 2028.","Proceeds to fund R&D, manufacturing, potential acquisitions; may retire convertible notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-000894","json":"https://secwatch.observer/filing/0001558370-23-000894.json","markdown":"https://secwatch.observer/filing/0001558370-23-000894.md","text":"https://secwatch.observer/filing/0001558370-23-000894.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285819/000155837023000894/0001558370-23-000894-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285819/000155837023000894/omer-20230206x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T23:54:39.042643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8037c9f7025c6b86cf5a25d3ad38b8d043b8f4ef","claim":"OMEROS CORP reported financial results for the year ended December 31, 2022.","evidence_excerpt":"U.S. net sales of OMIDRIA in 2022 totaled $131 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1285819/000155837023000894/0001558370-23-000894-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}